These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Erratum: Therapeutic effect of vascular interventional therapy andaspirin combined with defibrase on cerebral ischemia in rats. Li B; Geng S; Da Y Exp Ther Med; 2020 Jul; 20(1):678. PubMed ID: 32550889 [TBL] [Abstract][Full Text] [Related]
43. A novel synthetic inhibitor of factor Xa decreases early reocclusion and improves 24-h patency after coronary fibrinolysis in dogs. Abendschein DR; Baum PK; Verhallen P; Eisenberg PR; Sullivan ME; Light DR J Pharmacol Exp Ther; 2001 Feb; 296(2):567-72. PubMed ID: 11160645 [TBL] [Abstract][Full Text] [Related]
44. [Comparison of the efficacy of intravenous urokinase and defibrase on 6-hour-old canine coronary thrombosis]. Huang DX; Song AL; Yang XS Zhonghua Xin Xue Guan Bing Za Zhi; 1988 Dec; 16(6):363-5, 384. PubMed ID: 3248518 [No Abstract] [Full Text] [Related]
45. Defibrase, a purified fibrinolytic protease from snake venom in acute myocardial infarction. Huang DX; Gai LY; Wang SR; Li TD; Yang TS; Zhi G; Du LS; Li LH Acta Cardiol; 1992; 47(5):445-58. PubMed ID: 1441852 [TBL] [Abstract][Full Text] [Related]
46. Preventing subacute stent thrombosis--is there a role for heparin-coated stents? Carrozza JP J Invasive Cardiol; 2003 Aug; 15(8):442-3. PubMed ID: 12890873 [No Abstract] [Full Text] [Related]
47. [Comparison of defibrase and heparin in the prevention of thrombosis after coronary intervention]. Xiang D; Huang D; Ge L Zhonghua Nei Ke Za Zhi; 1997 Dec; 36(12):799-801. PubMed ID: 10451932 [TBL] [Abstract][Full Text] [Related]
48. [Complication of percutaneous coronary intervention--coronary dissection and acute closure]. Mitsudo K Nihon Rinsho; 2003 Apr; 61 Suppl 4():518-23. PubMed ID: 12735026 [No Abstract] [Full Text] [Related]